检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:王萍[1] 张文[2] 赵勇[1] 曾燕[1] Wang Ping;Zhang Wen;Zhao Yong;Zeng Yan(Department of Geriatric Cardiology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan 250021, China (Wang P, Zhao Y, Zeng Y;Department of Pharmacy, Shandong Provincial Hospital Affiliated to Shandong University, Jinan 250021, China( Zhang W)
机构地区:[1]山东大学附属省立医院老年心血管科,济南250021 [2]山东大学附属省立医院药学部,济南250021
出 处:《药物不良反应杂志》2018年第2期142-143,共2页Adverse Drug Reactions Journal
摘 要:1例79岁女性患者因继发性肺动脉高压给予波生坦62.5 mg、2次/d口服.用药前患者肝功能正常;用药第57天,实验室检查示天冬氨酸转氨酶(AST)44 U/L,丙氨酸转氨酶(ALT) 43 U/L,γ-谷氨酰转移酶(γ-GT)166 U/L,碱性磷酸酶(ALP)249 U/L,谷氨酸脱氢酶(GDH)30.8 U/L,白蛋白32 g/L,总胆红素(TBil)50.0 μmol/L,直接胆红素(DBil)23.8 μmol/L,间接胆红素(IBil)26.2 μmol/L;第62天,患者出现皮肤巩膜黄染、乏力、食欲减退,AST 39 U/L,ALT 32 U/L,GGT 276 U/L, ALP 417 U/L,GDH 14.5 U/L,白蛋白33 g/L,TBil 120.8 μmol/L,DBil 65.3 μmol/L,IBil 55.4 μmol/L,诊断为药源性肝损伤.停用波生坦,给予保肝药物治疗.停用波生坦后5d,黄疸消失;停用波生坦后33 d,AST 25 U/L,ALT 13 U/L,GGT 43 U/L,ALP 125 U/L,GDH 1.8 U/L,白蛋白37 g/L,TBil 24.0 μmol/L,DBil 9.2 μmol/L,IBil 14.8 μmol/L.A 79-year-old female patient with a secondary pulmonary hypertension received an oral bosentan 62.5 mg twice daily. Her liver function was normal before medication. On the day 57 after begining of the medication,laboratory tests showed aspartate aminotransferase(AST)44 U/L,alanine aminotransferase(ALT)43 U/L,gamma glutamyl transferase(γ-GT)166 U/L,alkaline phosphatase (ALP)249 U/L,glutamate dehydrogenase(GDH)30.8 U/L,albumin 31.7 g/L,total bilirubin(TBil) 50.0 μmol/L,direct bilirubin(DBil)23.8 μmol/L,and indirect bilirubin(IBil)26.2 μmol/L. On the day 62,the patient developed yellowish discoloration of skin and sclera,fatigue and loss of appetite. Laboratory tests showed the following levels:AST 39 U/L,ALT 32 U/L,GGT 276 U/L,ALP 417 U/L, GDH 14.5 U/L,albumin 33.6 g/L,TBil 120.8 μmol/L,DBil 65.3 μmol/L,IBil 55.4 μmol/L. Drug-induced liver injury was diagnosed. Bosentan was withdrawn and hepatoprotective agents were given. Five days after the drug withdrawal,her jaundice disappeared. Thirty-three days after the drug withdrawal,laboratory tests showed AST 25 U/L,ALT 13 U/L,GGT 43 U/L,ALP 125 U/L,GDH 1.8 U/L,albumin 37 g/L,TBil 24.0 μmol/L,DBil 9.2 μmol/L,and IBil 14.8 μmol/L.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:3.148.185.226